3 news items
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
ANNX
7 May 24
undesirable side effects or other properties of the company's product candidates; the company's reliance on third-party suppliers and manufacturers
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
ANNX
1 May 24
effects or other properties of the company's product candidates; the company's reliance on third-party suppliers and manufacturers; the outcomes of any
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
ANNX
26 Mar 24
reliance on third-party suppliers and manufacturers; the outcomes of any future collaboration agreements; and the company's ability to adequately
- Prev
- 1
- Next